These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Therapy with hydrazinopyridazine, a new antihypertensive vasodilatory agent, in combination with beta-receptor blocking substances. Kirch W; von Gizycki C Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):233-5. PubMed ID: 6104636 [No Abstract] [Full Text] [Related]
8. Withdrawal syndromes and the cessation of antihypertensive therapy. Hart GR; Anderson RJ Arch Intern Med; 1981 Aug; 141(9):1125-7. PubMed ID: 6114720 [TBL] [Abstract][Full Text] [Related]
10. A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms. Kampman KM; Dackis C; Lynch KG; Pettinati H; Tirado C; Gariti P; Sparkman T; Atzram M; O'Brien CP Drug Alcohol Depend; 2006 Nov; 85(2):129-37. PubMed ID: 16697124 [TBL] [Abstract][Full Text] [Related]
12. Clinical use of beta blockers in hypertension. Sleight P Aviat Space Environ Med; 1981 Nov; 52(11 Pt 2):S3-8. PubMed ID: 6118120 [TBL] [Abstract][Full Text] [Related]
13. [Effects of a new alpha- and beta-adrenoceptor blocking drug (YM-09538) on intraoperative hypertension]. Sha K; Furuya H; Kuro M; Kitaguchi K; Yamagishi N; Marunaka S; Shimoyama J; Okuda T Masui; 1988 Jul; 37(7):830-5. PubMed ID: 2906709 [No Abstract] [Full Text] [Related]
14. Cardiovascular effects of propranolol in patients with alcohol dependence during withdrawal. Kähkönen S; Bondarenko B; Lipsanen J; Zvartau E Int J Psychophysiol; 2007 Dec; 66(3):225-30. PubMed ID: 17761330 [TBL] [Abstract][Full Text] [Related]
15. [Anesthesia in patients under treatment with beta-receptor blocking agents]. Stienstra R; de Leeuw PW Ned Tijdschr Geneeskd; 1980 Nov; 124(44):1878-81. PubMed ID: 6107867 [No Abstract] [Full Text] [Related]
16. The role of beta blockers in alcohol withdrawal syndrome. Gottlieb LD Postgrad Med; 1988 Feb; Spec No():169-74. PubMed ID: 2894658 [TBL] [Abstract][Full Text] [Related]
17. Beta-adrenergic blocking therapy in hypertension: selection of patients. Frohlich ED; Tarazi RC; Dustan HP Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):151-6. PubMed ID: 4395481 [No Abstract] [Full Text] [Related]
18. Beta adrenergic blocking agents to control hypertension in aviation personnel. Schamroth CL; Davidoff R; Schamroth JM; Myburgh DP Aviat Space Environ Med; 1982 Apr; 53(4):403-4. PubMed ID: 6123307 [TBL] [Abstract][Full Text] [Related]
19. Regimen for the control of blood pressure and symptoms during clonidine withdrawal. Campbell BC; Reid JL Int J Clin Pharmacol Res; 1985; 5(4):215-22. PubMed ID: 4055164 [TBL] [Abstract][Full Text] [Related]
20. A long-term evaluation of nadolol, a long-acting beta-adrenergic blocking agent, in the management of hypertension in general practice. O'Callaghan EG Br J Clin Pract; 1982 Jun; 36(6):235-9. PubMed ID: 6128994 [No Abstract] [Full Text] [Related] [Next] [New Search]